Log In

Term Description

This panel includes results for phytanate and pristanate to investigate various peroxisomal disorders, including Zellweggers syndrome, Refsum disease, and adrenomyleoneuropathy, in which there is a defect in the metabolism or processing of long chain fatty acids. Symptoms range from life-threatening acute adrenal failure and severe hypotonia in neonates to progressive neurological deterioration and peripheral neuropathy in adults.

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINCNameR/O/CCardinalityExample UCUM Units
81763-5Phytanate and pristanate panel - Serum or Plasma
Indent22671-2Phytanate (C16:0(CH3)4) [Moles/volume] in Serum or Plasmaumol/L
Indent22761-1Pristanate (C15:0(CH3)4) [Moles/volume] in Serum or Plasmaumol/L

LOINC Names Get Info

Fully-Specified Name
Phytanate & pristanate panel:-:Pt:Ser/Plas:Qn:
Long Common Name
Phytanate and pristanate panel - Serum or Plasma
Short Name
Phytanate + pristanate Pnl SerPl
Display Name
Phytanate and pristanate panel
Consumer Name Alpha Get Info
Phytanate and Pristanate panel, Blood

Part Model Get Info

  • Component
    Phytanate & pristanate panel
    LP212164-0
    • Analyte
      Phytanate & pristanate panel
      LP212164-0
      • Component Numerator
        Phytanate & pristanate panel
        LP212164-0
        • Component Numerator Core
          Phytanate & pristanate panel
          LP212164-0
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    -
    LP6769-6
  • Time
    Pt
    LP6960-1
  • System
    Ser/Plas
    LP7576-4
    • System Core
      Ser/Plas
      LP7576-4
    • Super System
      NULL
       
  • Scale
    Qn
    LP7753-9
  • Method
    NULL
     

Basic Attributes

Class
PANEL.CHEM
Type
Laboratory
First Released
Version 2.56
Last Updated
Version 2.56 (ADD)
Order vs. Observation
Order
Panel Type
Panel

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Fytanát a pristanát panel:-:Časový bod:Sérum/plazma:Kvantitativní:
el-GRGreek (Greece)Πίνακας φυτανικού & πριστανικού:-:Pt:Ορός/Πλάσμα:Qn:
Synonyms: CHEM PANEL.CHEM Pt Qn Ορός Ορός/Πλάσμα Πίνακας φυτανικού & πριστανικού Πλάσμα Πριστανικό Φυτανικό
es-ESSpanish (Spain)Panel de Fitanato y pristanato:Propiedades mixtas (sólo paneles):Punto temporal:Suero o Plasma:Qn:
Synonyms: Cuantitativo
es-MXSpanish (Mexico)Panel de fitánato y pristanado:-:Punto temporal:Suero o Plasma:Cuantitativo:
fr-FRFrench (France)Phytanate et pristanate panel:-:Ponctuel:Sérum/Plasma:Numérique:
it-ITItalian (Italy)Fitanato & prostanato, panel:-:Pt:Siero/Plasma:Qn:
Synonyms: Chimica Fitanato (C16:0(CH3)4) Panel fitanato e prostanato Plasma Pristanato (C15:0(CH3)4) Punto nel tempo (episodio) Set di prescrizione chimica Siero Siero o Plasma
nl-NLDutch (Netherlands)fytanaat & pristanaat panel:-:moment:serum of plasma:kwantitatief:
zh-CNChinese (China)植烷酸与降植烷酸组套:-:时间点:血清/血浆:定量型:
Synonyms: 2,6,10,14-四甲基五癸酸;C16:0(CH3)4;植烷酸, C16:0(CH3)4 3,7,11,15-四甲基六癸酸;C15:0(CH3)4;降植烷酸, C15:0(CH3)4 化学;化学检验项目;化学检验项目类;化学类;化学试验;非刺激耐受型化学检验项目;非刺激耐受型化学检验项目类;非刺激耐受型化学试验;非刺激耐受型化学试验类 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.化学试验;化学组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;化学医嘱组类;医嘱组.化学;医嘱组.化学检验项目;医嘱组类.化学;医嘱组类.化学检验项目;医嘱组类.化学试验;实验室医嘱组类.化学;实验室医嘱组类.化学检验项目;实验室医嘱组类.化学试验 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 可用数量表示的;定量性;数值型;数量型;连续数值型标尺 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 植烷酸（2,6,10,14-四甲基五癸酸、C16:0(CH3)4、植烷酸, C16:0(CH3)4）与降植烷酸（3,7,11,15-四甲基六癸酸、C15:0(CH3)4、降植烷酸, C15:0(CH3)4）组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目） 组 组合 组合医嘱 组合类 组套 血清或血浆

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=81763-5
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/81763-5